Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs Sitagliptin in Liver Transplant Recipients with Diabetes
NCT05195944Phase 4Active, not recruiting
- Sponsor
- University Health Network
- Start
- Oct 2022
- Primary completion
- Dec 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in diabetes mellitus (DM), sponsored by University Health Network. Started Oct 2022; status: active, not recruiting.
02
Drugs
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT05195944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195944.